<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p151" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_151{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_151{left:799px;bottom:1132px;letter-spacing:-0.08px;}
#t3_151{left:141px;bottom:1081px;letter-spacing:0.14px;}
#t4_151{left:162px;bottom:1060px;letter-spacing:0.14px;}
#t5_151{left:534px;bottom:1060px;letter-spacing:0.14px;}
#t6_151{left:162px;bottom:1025px;letter-spacing:0.12px;word-spacing:1.29px;}
#t7_151{left:247px;bottom:1033px;letter-spacing:-0.03px;}
#t8_151{left:259px;bottom:1025px;letter-spacing:0.11px;word-spacing:1.29px;}
#t9_151{left:350px;bottom:1033px;letter-spacing:-0.03px;}
#ta_151{left:363px;bottom:1025px;letter-spacing:0.11px;word-spacing:1.28px;}
#tb_151{left:463px;bottom:1033px;letter-spacing:-0.03px;}
#tc_151{left:476px;bottom:1025px;letter-spacing:0.13px;word-spacing:1.29px;}
#td_151{left:566px;bottom:1033px;}
#te_151{left:571px;bottom:1025px;letter-spacing:0.12px;word-spacing:1.29px;}
#tf_151{left:682px;bottom:1033px;}
#tg_151{left:687px;bottom:1025px;letter-spacing:0.11px;word-spacing:1.29px;}
#th_151{left:784px;bottom:1033px;}
#ti_151{left:789px;bottom:1025px;letter-spacing:0.08px;word-spacing:1.28px;}
#tj_151{left:162px;bottom:1008px;letter-spacing:0.12px;}
#tk_151{left:211px;bottom:1016px;letter-spacing:-0.03px;}
#tl_151{left:227px;bottom:1008px;letter-spacing:0.13px;word-spacing:0.04px;}
#tm_151{left:347px;bottom:1016px;letter-spacing:-0.03px;}
#tn_151{left:162px;bottom:998px;}
#to_151{left:167px;bottom:990px;letter-spacing:0.12px;word-spacing:3.56px;}
#tp_151{left:632px;bottom:990px;}
#tq_151{left:644px;bottom:998px;}
#tr_151{left:649px;bottom:990px;letter-spacing:0.12px;word-spacing:3.56px;}
#ts_151{left:162px;bottom:972px;letter-spacing:0.11px;word-spacing:-0.08px;}
#tt_151{left:509px;bottom:972px;}
#tu_151{left:518px;bottom:980px;}
#tv_151{left:523px;bottom:972px;letter-spacing:0.1px;word-spacing:-0.09px;}
#tw_151{left:162px;bottom:955px;letter-spacing:0.12px;word-spacing:3.81px;}
#tx_151{left:749px;bottom:955px;}
#ty_151{left:761px;bottom:963px;}
#tz_151{left:766px;bottom:955px;letter-spacing:0.11px;}
#t10_151{left:162px;bottom:937px;letter-spacing:0.11px;word-spacing:0.79px;}
#t11_151{left:162px;bottom:920px;letter-spacing:0.11px;word-spacing:0.03px;}
#t12_151{left:162px;bottom:882px;letter-spacing:0.1px;word-spacing:0.03px;}
#t13_151{left:141px;bottom:825px;letter-spacing:0.17px;word-spacing:10.43px;}
#t14_151{left:719px;bottom:825px;letter-spacing:0.13px;}
#t15_151{left:162px;bottom:804px;letter-spacing:0.14px;}
#t16_151{left:254px;bottom:804px;letter-spacing:0.14px;word-spacing:-0.2px;}
#t17_151{left:162px;bottom:766px;letter-spacing:0.1px;word-spacing:0.03px;}
#t18_151{left:216px;bottom:774px;letter-spacing:-0.03px;}
#t19_151{left:229px;bottom:766px;}
#t1a_151{left:236px;bottom:766px;letter-spacing:0.12px;word-spacing:0.02px;}
#t1b_151{left:334px;bottom:774px;letter-spacing:-0.03px;}
#t1c_151{left:346px;bottom:766px;letter-spacing:0.11px;word-spacing:0.02px;}
#t1d_151{left:423px;bottom:774px;letter-spacing:-0.02px;}
#t1e_151{left:162px;bottom:756px;}
#t1f_151{left:167px;bottom:748px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1g_151{left:162px;bottom:731px;letter-spacing:0.12px;}
#t1h_151{left:252px;bottom:739px;}
#t1i_151{left:259px;bottom:731px;letter-spacing:0.08px;word-spacing:-0.39px;}
#t1j_151{left:162px;bottom:713px;letter-spacing:0.1px;word-spacing:-0.67px;}
#t1k_151{left:162px;bottom:678px;letter-spacing:0.12px;}
#t1l_151{left:259px;bottom:678px;letter-spacing:0.11px;word-spacing:7.19px;}
#t1m_151{left:439px;bottom:678px;letter-spacing:0.13px;word-spacing:7.19px;}
#t1n_151{left:162px;bottom:660px;letter-spacing:0.11px;word-spacing:0.35px;}
#t1o_151{left:162px;bottom:643px;letter-spacing:0.11px;word-spacing:0.34px;}
#t1p_151{left:162px;bottom:626px;letter-spacing:0.11px;}
#t1q_151{left:162px;bottom:608px;letter-spacing:0.13px;word-spacing:1.33px;}
#t1r_151{left:315px;bottom:608px;letter-spacing:0.12px;word-spacing:1.61px;}
#t1s_151{left:162px;bottom:590px;letter-spacing:0.13px;word-spacing:4.82px;}
#t1t_151{left:162px;bottom:573px;letter-spacing:0.12px;word-spacing:2.72px;}
#t1u_151{left:380px;bottom:573px;letter-spacing:0.19px;word-spacing:2.64px;}
#t1v_151{left:809px;bottom:573px;letter-spacing:0.14px;}
#t1w_151{left:162px;bottom:555px;letter-spacing:0.19px;}
#t1x_151{left:229px;bottom:555px;letter-spacing:0.15px;}
#t1y_151{left:430px;bottom:555px;letter-spacing:0.11px;word-spacing:0.04px;}
#t1z_151{left:162px;bottom:538px;letter-spacing:0.12px;}
#t20_151{left:218px;bottom:538px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t21_151{left:162px;bottom:520px;letter-spacing:0.1px;word-spacing:-0.77px;}
#t22_151{left:162px;bottom:502px;letter-spacing:0.11px;word-spacing:0.56px;}
#t23_151{left:162px;bottom:485px;letter-spacing:0.12px;word-spacing:4.14px;}
#t24_151{left:162px;bottom:467px;letter-spacing:0.12px;word-spacing:3.13px;}
#t25_151{left:162px;bottom:450px;letter-spacing:0.11px;word-spacing:1.93px;}
#t26_151{left:162px;bottom:432px;letter-spacing:0.08px;}
#t27_151{left:162px;bottom:415px;letter-spacing:0.12px;}
#t28_151{left:320px;bottom:415px;letter-spacing:0.11px;word-spacing:2.64px;}
#t29_151{left:162px;bottom:397px;letter-spacing:0.11px;word-spacing:0.72px;}
#t2a_151{left:162px;bottom:380px;letter-spacing:0.11px;word-spacing:1.11px;}
#t2b_151{left:162px;bottom:362px;letter-spacing:0.11px;word-spacing:1.23px;}
#t2c_151{left:162px;bottom:344px;letter-spacing:0.11px;word-spacing:1.16px;}
#t2d_151{left:162px;bottom:327px;letter-spacing:0.11px;word-spacing:-0.19px;}
#t2e_151{left:162px;bottom:309px;letter-spacing:0.11px;word-spacing:0.94px;}
#t2f_151{left:162px;bottom:292px;letter-spacing:0.1px;word-spacing:0.12px;}
#t2g_151{left:162px;bottom:274px;letter-spacing:0.14px;}
#t2h_151{left:291px;bottom:274px;letter-spacing:0.1px;word-spacing:-0.13px;}
#t2i_151{left:141px;bottom:218px;letter-spacing:0.16px;word-spacing:7.73px;}
#t2j_151{left:162px;bottom:196px;letter-spacing:0.13px;word-spacing:0.08px;}
#t2k_151{left:162px;bottom:162px;letter-spacing:0.12px;word-spacing:1.09px;}
#t2l_151{left:245px;bottom:170px;}
#t2m_151{left:250px;bottom:162px;}
#t2n_151{left:257px;bottom:162px;letter-spacing:0.13px;word-spacing:1.56px;}
#t2o_151{left:343px;bottom:170px;}
#t2p_151{left:348px;bottom:162px;letter-spacing:0.11px;word-spacing:0.56px;}
#t2q_151{left:438px;bottom:170px;}
#t2r_151{left:443px;bottom:162px;letter-spacing:0.12px;word-spacing:0.75px;}
#t2s_151{left:599px;bottom:170px;}
#t2t_151{left:162px;bottom:152px;}
#t2u_151{left:167px;bottom:144px;letter-spacing:0.11px;word-spacing:0.32px;}
#t2v_151{left:162px;bottom:135px;}
#t2w_151{left:167px;bottom:127px;letter-spacing:0.11px;word-spacing:-0.39px;}
#t2x_151{left:162px;bottom:90px;letter-spacing:0.12px;}
#t2y_151{left:256px;bottom:90px;letter-spacing:0.12px;word-spacing:3.47px;}

.s0_151{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_151{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_151{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s3_151{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s4_151{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
.s5_151{font-size:10px;font-family:TimesNewRomanPS-BoldMT_8j;color:#000;}
.s6_151{font-size:18px;font-family:TimesNewRomanPS-BoldItalicMT_8s;color:#000;}
.s7_151{font-size:15px;font-family:TimesNewRomanPS-ItalicMT_8n;color:#000;}
.t.v0_151{transform:scaleX(0.941);}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts151" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldItalicMT_8s;
	src: url("fonts/TimesNewRomanPS-BoldItalicMT_8s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_8j;
	src: url("fonts/TimesNewRomanPS-BoldMT_8j.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-ItalicMT_8n;
	src: url("fonts/TimesNewRomanPS-ItalicMT_8n.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg151Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg151" style="-webkit-user-select: none;"><object width="935" height="1210" data="151/151.svg" type="image/svg+xml" id="pdf151" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_151" class="t s0_151">Brain: Chemistry to Cognition </span><span id="t2_151" class="t s1_151">143 </span>
<span id="t3_151" class="t s2_151">P112: Parkinson’s disease -related neuroinflammation controlled by the </span>
<span id="t4_151" class="t s2_151">phosphorylation of cytosolic phospholipase A2 </span><span id="t5_151" class="t s2_151">through cyclin-dependent kinase 5 </span>
<span id="t6_151" class="t s3_151">Sangita Paul </span>
<span id="t7_151" class="t s4_151">1,2 </span>
<span id="t8_151" class="t s0_151">, Saman Fatihi </span>
<span id="t9_151" class="t s4_151">1,2 </span>
<span id="ta_151" class="t s0_151">, Srishti Sharma </span>
<span id="tb_151" class="t s4_151">1,2 </span>
<span id="tc_151" class="t s0_151">, Rintu Kutum </span>
<span id="td_151" class="t s4_151">1 </span>
<span id="te_151" class="t s0_151">, Raymond Fields </span>
<span id="tf_151" class="t s4_151">3 </span>
<span id="tg_151" class="t s0_151">, Harish C Pant </span>
<span id="th_151" class="t s4_151">4 </span>
<span id="ti_151" class="t s0_151">, Lipi </span>
<span id="tj_151" class="t s0_151">Thukral </span>
<span id="tk_151" class="t s4_151">1,2 </span>
<span id="tl_151" class="t s0_151">and Binukumar BK </span>
<span id="tm_151" class="t s4_151">1,2 </span>
<span id="tn_151" class="t s4_151">1 </span>
<span id="to_151" class="t s0_151">CSIR Institute of Genomics and Integrative Biology, New Delhi, India</span><span id="tp_151" class="t s3_151">; </span>
<span id="tq_151" class="t s5_151">2 </span>
<span id="tr_151" class="t s0_151">Academy of Scientific and </span>
<span id="ts_151" class="t s0_151">Innovative Research (AcSIR), Ghaziabad- 201002, India</span><span id="tt_151" class="t s3_151">; </span>
<span id="tu_151" class="t s5_151">3 </span>
<span id="tv_151" class="t s0_151">Viral Production Core Facility, National Institute </span>
<span id="tw_151" class="t s0_151">of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA</span><span id="tx_151" class="t s3_151">; </span>
<span id="ty_151" class="t s5_151">4 </span>
<span id="tz_151" class="t s0_151">Neuronal </span>
<span id="t10_151" class="t s0_151">Cytoskeletal Protein Regulation Section, National Institute of Neurological Disorders and Stroke, National </span>
<span id="t11_151" class="t s0_151">Institutes of Health, Bethesda, MD, USA </span>
<span id="t12_151" class="t s0_151">Abstract not available </span>
<span id="t13_151" class="t s2_151">P113: Small Organism, Big Hope: Secondary metabolites from </span><span id="t14_151" class="t s6_151">Dictyostelium </span>
<span id="t15_151" class="t s6_151">discoideum </span><span id="t16_151" class="t s2_151">as innovative interventions for Alzheimer's disease </span>
<span id="t17_151" class="t s3_151">Nil Patil </span>
<span id="t18_151" class="t s5_151">1,2 </span>
<span id="t19_151" class="t s3_151">, </span><span id="t1a_151" class="t s0_151">Rupal Dhariwal </span>
<span id="t1b_151" class="t s4_151">1,2 </span>
<span id="t1c_151" class="t s0_151">, Mukul Jain </span>
<span id="t1d_151" class="t s4_151">1,2 </span>
<span id="t1e_151" class="t s4_151">1 </span>
<span id="t1f_151" class="t s0_151">Cell and Developmental biology lab, Research and Development Cell, Parul University, Vadodara 391760, </span>
<span id="t1g_151" class="t s0_151">Gujarat,India; </span>
<span id="t1h_151" class="t s4_151">2 </span>
<span id="t1i_151" class="t s0_151">Department of Life Sciences, Parul Institute of Applied Sciences, Parul University, Vadodara </span>
<span id="t1j_151" class="t s0_151">391760, Gujarat, India. </span>
<span id="t1k_151" class="t s3_151">Background: </span><span id="t1l_151" class="t s7_151">Dictyostelium discoideum, </span><span id="t1m_151" class="t s0_151">a eukaryotic microorganism, produces diverse secondary </span>
<span id="t1n_151" class="t s0_151">metabolites (polyketides, terpenes, flavonoids) across various developmental stages with antibacterial, anti- </span>
<span id="t1o_151" class="t s0_151">aggregative, and anti-amyloidic properties. This study focuses on isolation and characterization of screened </span>
<span id="t1p_151" class="t s0_151">secondary metabolites against AD. </span>
<span id="t1q_151" class="t s3_151">Materials and methods</span><span id="t1r_151" class="t s0_151">: Screening of metabolites (SWISS - ADME) and receptors specific to AD were </span>
<span id="t1s_151" class="t s0_151">scrutinized through network pharmacology (CytoHubba, GO, and KEGG resources) and subsequent </span>
<span id="t1t_151" class="t s0_151">screening through AutoDock and </span><span id="t1u_151" class="t v0_151 s0_151">GROMACS. Among these, the selected compound was isolated from </span><span id="t1v_151" class="t v0_151 s7_151">D. </span>
<span id="t1w_151" class="t v0_151 s7_151">discoideum</span><span id="t1x_151" class="t v0_151 s0_151">, and subjected to characterization </span><span id="t1y_151" class="t s0_151">using analytical techniques - GC-MS and NMR </span>
<span id="t1z_151" class="t s3_151">Results: </span><span id="t20_151" class="t s0_151">Following initial screening, six compounds were selected and underwent hybrid approach involving </span>
<span id="t21_151" class="t s0_151">database and compound-centric target identification led to the selection of three receptors (CYP19A1, COX2, </span>
<span id="t22_151" class="t s0_151">mTOR), prioritized over GO enrichment and KEGG analysis. The resulting metabolite-receptor complexes </span>
<span id="t23_151" class="t s0_151">underwent validation via molecular docking and molecular dynamics (MD) simulation. The ultimate </span>
<span id="t24_151" class="t s0_151">compound was isolated and subjected to characterization using GC-MS, which identified Discoidol (a </span>
<span id="t25_151" class="t s0_151">Terpene) as a prominent constituent with a retention time of 19.23 minutes and 100% abundance in the </span>
<span id="t26_151" class="t s0_151">extract. </span>
<span id="t27_151" class="t s3_151">Discussion/Conclusion: </span><span id="t28_151" class="t s0_151">This study explores the utilization of secondary metabolites from a eukaryotic </span>
<span id="t29_151" class="t s0_151">model organism in a therapeutic approach to develop a cost-effective, less harmful, and relatively efficient </span>
<span id="t2a_151" class="t s0_151">drug for AD treatment. The extract was highly comprised with Discoidol and had affinity for COX2. The </span>
<span id="t2b_151" class="t s0_151">COX2 enhances amyloid-beta production and thus,its targeted inhibition using Discoidol was focused on. </span>
<span id="t2c_151" class="t s0_151">Moreover, the Discoidol’s PROTOX validation indicates its least toxic behavior towards human cells and </span>
<span id="t2d_151" class="t s0_151">organs in comparison with the referred drug Indomethacin that have a hepatotoxic property causing upraised </span>
<span id="t2e_151" class="t s0_151">level of drug degrading enzymes. Thus, Discoidol could be considered for pre-clinical and drug discovery </span>
<span id="t2f_151" class="t s0_151">purpose against AD in near future. </span>
<span id="t2g_151" class="t s3_151">Acknowledgments: </span><span id="t2h_151" class="t s0_151">The Parul University, Vadodara for providing funding support to this project. </span>
<span id="t2i_151" class="t s2_151">P114: Cell-free therapy against neurodegeneration as a double-edged sword of </span>
<span id="t2j_151" class="t s2_151">extracellular vesicles and organelles </span>
<span id="t2k_151" class="t s3_151">Shalini Raik </span>
<span id="t2l_151" class="t s5_151">1 </span>
<span id="t2m_151" class="t s3_151">, </span><span id="t2n_151" class="t s0_151">Mohil Mishra </span>
<span id="t2o_151" class="t s4_151">1 </span>
<span id="t2p_151" class="t s0_151">, Vidya Rattan </span>
<span id="t2q_151" class="t s4_151">2 </span>
<span id="t2r_151" class="t s0_151">, Shalmoli Bhattacharyya </span>
<span id="t2s_151" class="t s4_151">1 </span>
<span id="t2t_151" class="t s4_151">1 </span>
<span id="t2u_151" class="t s0_151">Department of Biophysics, Post Graduate Institute of Medical Education and Research, Chandigarh, India; </span>
<span id="t2v_151" class="t s4_151">2 </span>
<span id="t2w_151" class="t s0_151">Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India </span>
<span id="t2x_151" class="t s3_151">Background: </span><span id="t2y_151" class="t s0_151">MSCs have been involved in promoting neural repair, regeneration, axonal connection, </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
